Paracetamol, Codeine Phosphate Hemihydrate

3 trials 1 recruiting NNeurology/Psychiatry

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

2 Sponsors

7 Countries

Phase II

Phase IV

Phase II: 2 Phase IV: 1

Oversight events:

3 temporary halts across 1 trial

View oversight register →

Sponsors using this IMP

Novartis Pharma AG 2 University Hospital Of Clermont-Ferrand 1

All trials

3 total

Management of moderate to severe monotraumatic pain with sublingual Sufentanil in an emergency situation. Recruiting

2024-519217-64-00 Phase IV 1 country University Hospital Of Clermont-Ferrand
A proof-of-concept study to examine QUC398 in participants with knee osteoarthritis Ended

2023-509274-28-00 Phase II 3 countries Novartis Pharma AG
Study of efficacy, safety and tolerability of DFV890 in patients with knee osteoarthritis Ended

2023-507559-30-00 Phase II 5 countries Novartis Pharma AG

Showing 1–3 of 3 trials

← All drugs A–Z